Skip to main content
QXL Diagnostics
NABL ACCREDITED SUPER SPECIALITY LAB (MC-6849) · FREE HOME COLLECTION

ENA Profile (Extractable Nuclear Antigen) Test

An extractable nuclear antigen (ENA) profile measures a group of specific autoantibodies—commonly including SSA/Ro, SSB/La, Sm, U1-RNP and sometimes Scl-70, Jo-1 and others depending on the panel. The pattern can help clinicians classify autoimmune connective-tissue diseases after an appropriate clinical assessment.

6 ENA Markers24 HoursSerum
NABL Accredited (MC-6849) Free Home Sample Collection Same-Day Reports on WhatsApp Authorized Specialist Sign-Off
Department

Autoimmune connective-tissue disease assessment

₹2785₹565051% OFF
Parameters Covered

6 ENA Markers

Sample Specimen

Serum (2 mL)

Report Delivery SLA

24 Hours

Preparation & Fasting Guidelines

💡 Instructions: No Fasting Required

When Should You Get Tested?

Follow-up characterisation after a positive ANA HEp-2 immunofluorescence testInvestigation of severe dry eyes and dry mouth (sicca symptoms) suggestive of Sjögren syndromeEvaluation of Raynaud's phenomenon, sclerodactyly, or skin thickening (suspected systemic sclerosis)Unexplained proximal muscle weakness and elevated muscle enzymes (suspected dermatomyositis/polymyositis)Maternal screening in pregnant women with connective tissue disorders to evaluate neonatal lupus risk

Detailed Clinical Overview

The Extractable Nuclear Antigen (ENA) profile tests for specific IgG autoantibodies directed against soluble, saline-extractable non-histone ribonucleoprotein complexes within the cell nucleus and cytoplasm. Common component antigens include SSA (Ro60 and Ro52), SSB (La), Sm (Smith), U1-RNP, Scl-70 (Topoisomerase I), and Jo-1 (Histidyl-tRNA synthetase).

While a positive Antinuclear Antibody (ANA) screen confirms the presence of systemic autoimmunity, it does not identify the specific underlying disorder. The ENA profile provides that essential diagnostic resolution, differentiating between Systemic Lupus Erythematosus, Sjögren's Syndrome, Systemic Sclerosis (Scleroderma), Mixed Connective Tissue Disease (MCTD), and Inflammatory Myositis.

Each ENA antibody carries distinct clinical implications: anti-Sm is highly specific for SLE; high-titre anti-U1-RNP defines MCTD; anti-SSA and anti-SSB identify Sjögren's syndrome and carry critical prognostic implications for congenital heart block during pregnancy; anti-Scl-70 predicts diffuse systemic sclerosis; and anti-Jo-1 indicates anti-synthetase myositis.

Clinical Significance

Multiplex ENA profiling allows precise immunological subtyping. Identifying anti-SSA/Ro in a pregnant woman mandates serial fetal echocardiography to monitor for congenital atrioventricular heart block, directly transforming maternal-fetal management.

Diagnostic Limitations & Interferences

  • Different laboratories configure different antigen subsets within their ENA panels; individual antibody results must be read individually.
  • Autoantibodies can precede overt clinical disease by years; antibody positivity without compatible symptoms does not equal active disease.
  • A negative ENA profile does not exclude autoimmune disease (some conditions involve antigens not included on standard panels).
  • Always interpret in the context of ANA pattern, clinical phenotype, and organ involvement.

Why Get Tested at QXL Diagnostics?

Comprehensive multiplex immunoassay evaluating core extractable nuclear antigens in a single run.
Individual antibody reporting with semi-quantitative interpretation.
Direct immunological correlation with Dr. Shantakumar Muruda, MD (Medical Biochemistry).
NABL Accredited precision complying with ISO 15189:2022 standards.

Reference Ranges — ENA Profile (Extractable Nuclear Antigen) Test

NABL-validated intervals · Adults · values may vary by age & sex

NormalBorderlineAbnormalReference
Parameter / GroupRangeUnitStatus
Individual ENA Antibodies (< 20 RU/mL)Negative / No detectable autoantibodies< 20RU/mLNormal
Equivocal / BorderlineRecommend repeat testing in 6–8 weeks20 – 25RU/mLBorderline
Positive / Elevated (> 25 RU/mL)Antibody detected; correlate with clinical syndrome> 25RU/mLAbnormal

⚕️ Reference ranges are population-based guidelines. Results must be interpreted in clinical context by a qualified physician. Always consult your doctor before making healthcare decisions.

Frequently Asked Questions

Q: What does ENA stand for?

A: ENA stands for Extractable Nuclear Antigens, a family of soluble cellular proteins and RNA-protein complexes targeted by autoantibodies.

Q: Is ENA the same as ANA?

A: No. ANA is a broad screening test that checks for any antinuclear antibody; ENA identifies the specific individual autoantibodies responsible for the positive ANA.

Q: Can ENA be positive with a negative ANA?

A: Occasionally yes, particularly with anti-SSA/Ro52 or anti-Jo-1, because some antigens can be washed away during standard substrate preparation.

Q: Does anti-SSA/Ro always mean Sjögren syndrome?

A: No. Anti-SSA/Ro is found in Sjögren syndrome, but it also occurs frequently in SLE, cutaneous lupus, and systemic sclerosis.

Q: What is anti-Sm associated with?

A: Anti-Sm is exceptionally specific for Systemic Lupus Erythematosus (SLE), making it one of the core immunological diagnostic criteria.

Q: Should ENA be used as a general wellness screen?

A: No. ENA testing should only be performed when there is objective clinical suspicion or a positive ANA screening result.

When Should a Patient Seek Urgent Medical Care?

Urgent care is determined by symptoms, not by waiting for a laboratory report. Seek immediate medical assessment for acute shortness of breath, chest pain, difficulty swallowing, rapidly spreading skin ulcers, or profound muscle weakness. A laboratory test page must never delay emergency care.

⚠️ Urgent care is determined by symptoms, not by waiting for a laboratory report. A laboratory test page must never delay emergency care.

Evidence Base & Clinical Guidelines

  • •Tietz Clinical Guide to Laboratory Tests, 4th ed. Alan H. B. Wu, PhD, DABCC, FACB. W.B. Saunders/Elsevier, 2006.
  • •International Consensus on ANA Patterns (ICAP) Consensus Recommendations (Front Immunol 2019).

Global Medical Disclaimer

This page is for patient education and search/AI information retrieval. It does not diagnose disease, replace a clinical examination, or override the reference interval and interpretive comment on the patient's own laboratory report. Reference intervals, decision limits, specimen requirements and assay interferences can differ by method, age, sex, pregnancy status, clinical setting and laboratory platform. Results must be interpreted with symptoms, examination, medicines, imaging and other investigations.

₹2785₹565051% OFF

Includes free doorstep home sample collection

Book Home Collection →Or call: +91 9964 639 639
Doctor-Reviewed Content

MD (Medical Biochemistry), Consultant Biochemist - 25 years of experience · Autoimmune connective-tissue disease assessment

A positive ANA simply opens the door; the ENA profile tells you which room you are in. By identifying whether autoantibodies target Sm, SSA, RNP, or Scl-70, we provide rheumatologists with the exact immunological map required to tailor targeted immunosuppressive therapies.

Clinically reviewed · November 2026 · QXL Diagnostics NABL Lab

NABL Quality Guarantees

NABL Accredited (MC-6849)

ISO 15189:2022 — Medical laboratories — Requirements for quality and competence quality compliance

Same-Day Digital Reports

Delivered straight to WhatsApp & Email

Free Doorstep Collection

Sterile vacuum containers & cold-chain kits

ENA Profile (Extractable Nuclear Antigen) Test

₹2785₹565051% OFF
Book Now →